Al-Razi Medical Co.
9572.SRSAUHealthcare● Active
$29.22
+$0.90(+3.18%)
Market Cap$44414400
P/E Ratio—
52W High$45.7
52W Low$25.1
Al-Razi Medical Co.（9572.SR）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · 9572.SR · 截至 2026-06-15
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $74.38M | $61.35M | $61.33M | $52.39M | $45.19M |
| Cost of Revenue | $55.09M | $44.76M | $44.03M | $38.84M | $33.98M |
| Gross Profit | $19.30M | $16.59M | $14.07M | $13.55M | $11.21M |
| Gross Margin %(computed) | 25.94% | 27.04% | 22.95% | 25.87% | 24.81% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $1.34M | $1.23M | $1.26M | $1.13M | $1.76M |
| Total Operating Expenses | $17.72M | $16.15M | $12.26M | $10.66M | $8.56M |
| Operating Income | $1.57M | $0.43M | $1.81M | $2.89M | $2.65M |
| Operating Margin %(computed) | 2.12% | 0.71% | 2.96% | 5.52% | 5.85% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.90M | $0.48M | $0.30M | $0.60M |
| Income Before Tax | $1.07M | $0.53M | $1.09M | $2.43M | $2.53M |
| Income Tax Expense | $0.25M | $0.35M | $0.40M | $0.41M | $0.37M |
| Net Income | $0.82M | $0.18M | $0.69M | $2.01M | $2.16M |
| Net Margin %(computed) | 1.10% | 0.29% | 1.12% | 3.84% | 4.79% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.54 | $0.12 | $0.45 | $1.33 | $1.42 |
| Wtd Avg Shares | 1.52M | 1.47M | 1.52M | 1.52M | 1.52M |
| EBITDA | $1.57M | $0.43M | $5.07M | $5.72M | $5.12M |
| EBITDA Margin %(computed) | 2.12% | 0.71% | 8.27% | 10.92% | 11.34% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-15 · SAR · M
深入了解Al-Razi Medical Co.
关于Al-Razi Medical Co.（9572.SR）损益表
Al-Razi Medical Co.（9572.SR）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，9572.SR实现营收$0.07B，毛利润$0.02B（毛利率25.94%），净利润$0.00B（净利率1.10%）。
常见问题
9572.SR · 4 问Al-Razi Medical Co.（9572.SR）2025财年营收为$0.07B，同比up21.2%。
9572.SR revenue9572.SR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15